Issue 3, 2021

Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer

Abstract

Antibody-recruiting molecules (ARMs) are one of the most promising tools to redirect the immune response towards cancer cells. In this review, we aim to highlight the recent advances in the field. We will illustrate the advantages of different ARM approaches and emphasize the importance of a multivalent presentation of the binding units.

Graphical abstract: Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer

Associated articles

Article information

Article type
Review Article
Submitted
07 Jan 2021
Accepted
07 Feb 2021
First published
04 Mar 2021
This article is Open Access
Creative Commons BY-NC license

RSC Chem. Biol., 2021,2, 713-724

Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer

S. Achilli, N. Berthet and O. Renaudet, RSC Chem. Biol., 2021, 2, 713 DOI: 10.1039/D1CB00007A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements